Inducing Hypermutability to Promote Anti–PD-1 Therapy Response is a research paper published in Cancer Discovery (2022). On theSindex it has a DataRank of 0.245. It has been cited 3 times, with 3 citing works in its 1-hop citation network.
Scored on demand from live citation data
Repositories this paper deposited data in (declared in PubMed).
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
Base Score Contribution
0.208
From this paper's citation signal
Citation Network Contribution
0.0375
From 3 citing papers with measurable signal
Ranked by each citer's contribution to N(p) — log1p(Cq) divided by its reference count — out of 3 citers.
SPORE
Grant: P50CA221707
NIH NCI
Grant: P30 CA016672
University of Texas Anderson Cancer Center Core Support Grant NCI Paul Calabresi Clinical Oncology Program Award
Grant: K12 CA088084-20
National Institutes of Health
Grant: 5K12CA088084-02
CLINICAL ONCOLOGY RESEARCH CAREER DEVELOPMENT PROGRAM
National Institutes of Health
Grant: 3P30CA016672-41S4
Cancer Center Support (CORE) Grant
National Institutes of Health
Grant: 5P50CA221707-03
MD Anderson Cancer Center SPORE in Gastrointestinal Cancer
NCI NIH HHS
Grant: K12 CA088084
FWCI
0.28
Citation Percentile
0.5%
Citation Trend
Fields of Study
MeSH Terms
Keywords